What You Should Know:
– Thoughtful.ai, a company specializing in artificial intelligence (AI)-powered revenue cycle automation has received a strategic investment from New Mountain Capital, a growth-oriented investment firm with over $55B in assets under…
Continue Reading
It seems as if the conversation about how to use artificial intelligence across industries has gone on for several years since the explosive growth of generative AI tools.
Walk into any office space, and it’s…
Mark Koeniguer, Chief Commercial Officer at iCAD
What You Should Know:
– iCAD, Inc., a provider of clinically proven AI-powered breast health solutions, today announced the appointment of Mark Koeniguer as its Chief Commercial Officer (CCO).
–…
Continue Reading
Biotechnology and precision medicine company Caris Life Sciences announced it raised $168 million in growth capital funding.Caris Life Sciences has now raised $1.86 billion in capital since 2018.
Braidwell LP led the round with participation…
Thatch, an employer-focused health benefits platform, has secured $40 million in a Series B funding, bringing its total raise to $84.5 million. Index Ventures led the round, with participation from existing investors Andreessen Horowitz (a16z),…
Continue Reading
The Evolving Orphan Drug Landscape
Once considered specialized treatments for rare conditions, orphan drugs are now challenging the dominance of mainstream medications in the pharmaceutical industry. According to two recent Evaluate reports—”Are Orphans That Different?”…
This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive.
Health tech companies made several major funding announcements in March. Here is…
Continue Reading
A targeted focus on HealthTech has the potential to boost the UK’s global competitiveness, writes Russ Shaw, founder of Tech London Advocates and Global Tech Advocates
The UK’s economic growth of late has been sluggish,…
The rise in direct-to-patient therapeutics access via online compounding pharmacies and other direct-to-patient sales models has increased the likelihood of patients utilizing medications alongside other therapeutics and with various complex co-morbidities.
With the growth of…
Continue Reading
Rapid growth in genetic testing usage resulted in declining availability of genetic counselors (GCs) per ordered tests, prolonging the waiting times for face-to-face (F2F) counseling. We evaluated the digital genetic assistant (DGA) for reproductive…
Continue Reading
